Every individual carries a unique genetic heritage, a distinct metabolism, a singular microbiome. No one disputes this biological fact. Yet every morning, millions of people swallow the same standardized tablet. Multivitamins now represent a global market worth over $50 billion, and the scientific literature keeps accumulating data that challenges their relevance in this generic form.
This is an absurdity.
The fundamental problem: blind standardization
When a laboratory formulates a multivitamin, it relies on Recommended Daily Allowances (RDAs), also known as Nutrient Reference Values (NRVs). These values cover the needs of 97.5% of the general population (PubMed). They ignore your age, your physical activity level, your genetic polymorphisms. MTHFR variants, which affect folate metabolism, are simply not accounted for. Neither is your actual diet.
Take vitamin D.
European RDAs recommend 5 µg (200 IU) per day. Observational studies show that individual requirements vary by a factor of 1 to 10 (PubMed). Skin pigmentation, sun exposure, body mass index, latitude of residence: each parameter changes the equation. A single uniform intake is, by definition, inadequate for the vast majority of individuals.
Vitamin D requirements can vary by a factor of 1 to 10 between two individuals, depending on their genetics, sun exposure, and body composition.
Fat-soluble vitamins: when excess becomes the problem
The distinction between water-soluble vitamins (B group, vitamin C) and fat-soluble vitamins (A, D, E, K) is fundamental to understanding the limitations of multivitamins. Excess water-soluble vitamins are eliminated through urine. The overdose risk is low. Fat-soluble vitamins, however, accumulate in adipose tissue and the liver.
The SELECT trial illustrates this problem with brutal clarity. This randomized study followed over 35,000 men. The group supplemented with vitamin E (400 IU/day) showed a significant increase in prostate cancer risk compared to placebo (PubMed).
Supplementing without measuring is methodological recklessness.
The ignored taxonomy: essentials and geroprotectors do not belong in the same category
The multivitamin treats all bioactives as interchangeable. Yet supplementation science distinguishes two fundamentally different categories.
Essentials comprise the vitamins and minerals that the body does not synthesize in sufficient quantities: magnesium, zinc, vitamin D3, vitamin B12, iron, iodine. Depleted soils, industrial food, and sedentary lifestyles create near-universal increased nutritional needs. But "near-universal" does not mean "identical." Two individuals of the same age, living in the same city, can present radically different vitamin D levels depending on their genetics (VDR receptor, the protein that allows cells to capture vitamin D), body fat (D3 is fat-soluble and "dilutes" in adipose tissue), and sun exposure (PubMed).
Geroprotectors (literally "aging protectors") form a distinct category: glycine, alpha-ketoglutarate (AKG), NAD+ precursors (NMN/NR, molecules that fuel the production of NAD+, a coenzyme essential for cellular energy metabolism), taurine. These are molecules the body no longer produces in sufficient quantities with age, and whose role in the fundamental mechanisms of cellular aging is an active area of research. No standard multivitamin contains them. And for good reason: their relevance depends on the individual biological profile, not on an RDA percentage.
The Cell study by Zeevi et al. (2015) on personalized glycemic response established a finding that has become foundational: two people eating the same food can have radically different metabolic responses (PubMed). This N=1 biology principle applies directly to supplementation. Interindividual variability renders any universal formula structurally inadequate, whether we are discussing essentials or geroprotectors.
The biomarker approach: supplementing what is actually needed
Precision nutrition offers a radically different alternative: instead of hypothetically filling all possible nutrient gaps, it begins by measuring the actual biological state of each individual. A targeted blood panel evaluates circulating levels of key micronutrients. 25(OH)D (the circulating form of vitamin D) for vitamin D. Ferritin (the iron storage protein) for iron. Homocysteine and intra-erythrocyte B12 (B12 stored inside red blood cells, more reliable than serum B12) for B12 status. Erythrocyte magnesium (magnesium inside red blood cells) for intracellular magnesium.
From this biological snapshot, personalized supplementation becomes possible. Nutrients are calibrated according to the actual need, not a statistical average (PubMed). Negative interactions disappear (absorption competition between iron/zinc, calcium/magnesium). Regular panels allow the formulation to be adjusted over time, accounting for seasonal, dietary, and activity changes.
Micronutrients are essential. The most widespread method of delivering them is not. The universal tablet rests on statistical logic that individual biochemistry contradicts with every measurement.
Precision is not a luxury. It is the only approach that respects your biology.
Frequently asked questions
References
- Otten JJ, Hellwig JP, Meyers LD. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. National Academies Press, 2006 (PubMed).
- Cashman KD et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033-1044 (PubMed).
- Melhus H et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med. 1998;129(10):770-778 (PubMed).
- Klein EA et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549-1556 (PubMed).
- Ordovas JM, Ferguson LR, Tai ES, Mathers JC. Personalised nutrition and health. BMJ. 2018;361:bmj.k2173 (PubMed).
- Zeevi D, Korem T, Zmora N, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015;163(5):1079-1094 (PubMed).
